{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:44:49Z","timestamp":1793313889416,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2023\/49\/N\/NZ5\/01525"],"award-info":[{"award-number":["2023\/49\/N\/NZ5\/01525"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lfs.2026.124474","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T06:46:19Z","timestamp":1779518779000},"page":"124474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Kynurenine pathway impact on immune evasion and inflammation in acute myeloid leukemia"],"prefix":"10.1016","volume":"400","author":[{"given":"Katarzyna","family":"Wawrzak-Pienkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Golonko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ignatiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Swidnicka-Siergiejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pienkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124474_bb0005","doi-asserted-by":"crossref","unstructured":"Bolkun, L., Pienkowski, T., Sieminska, J., Godzien, J., Pietrowska, K., K\u0142oczko, J., Wierzbowska, A., Moniuszko, M., Ratajczak, M., Kretowski, A., Ciborowski, M., 2023. Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy. Sci. Rep. 2023 13:1 13, 1\u201311. doi:https:\/\/doi.org\/10.1038\/s41598-023-48970-0.","DOI":"10.1038\/s41598-023-48970-0"},{"key":"10.1016\/j.lfs.2026.124474_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108848","article-title":"Investigation into biased signaling, glycosylation, and drug vulnerability of acute myeloid leukemia","volume":"270","author":"Pienkowski","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2026.124474_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70188","article-title":"Inflammatory signaling in the pathogenesis of acute myeloid leukemia","volume":"9","author":"Baumann","year":"2025","journal-title":"Hemasphere"},{"key":"10.1016\/j.lfs.2026.124474_bb0020","doi-asserted-by":"crossref","first-page":"1000996","DOI":"10.3389\/fimmu.2022.1000996","article-title":"The cytokine network in acute myeloid leukemia","volume":"13","author":"Luciano","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16233974","article-title":"Inflammation and related signaling pathways in acute myeloid leukemia","volume":"16","author":"Naji","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124474_bb0030","doi-asserted-by":"crossref","unstructured":"Lasry, A., Nadorp, B., Fornerod, M., Nicolet, D., Wu, H., Walker, C.J., Sun, Z., Witkowski, M.T., Tikhonova, A.N., Guillamot-Ruano, M., Cayanan, G., Yeaton, A., Robbins, G., Obeng, E.A., Tsirigos, A., Stone, R.M., Byrd, J.C., Pounds, S., Carroll, W.L., Gruber, T.A., Eisfeld, A.K., Aifantis, I., 2022. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat. Can. 2022 4:1 4, 27\u201342. doi:https:\/\/doi.org\/10.1038\/s43018-022-00480-0.","DOI":"10.1038\/s43018-022-00480-0"},{"key":"10.1016\/j.lfs.2026.124474_bb0035","doi-asserted-by":"crossref","unstructured":"Berthon, C., Driss, V., Liu, J., Kuranda, K., Leleu, X., Jouy, N., Hetuin, D., Quesnel, B., 2010. In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunol. Immunother. 2010 59:12 59, 1839\u20131849. doi:https:\/\/doi.org\/10.1007\/S00262-010-0909-Y.","DOI":"10.1007\/s00262-010-0909-y"},{"key":"10.1016\/j.lfs.2026.124474_bb0040","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12032-010-9459-6","article-title":"Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells","volume":"28","author":"El Kholy","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.lfs.2026.124474_bb0045","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3324\/haematol.2010.025924","article-title":"Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells","volume":"95","author":"Curti","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2026.124474_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01918","article-title":"ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells","volume":"8","author":"Lecciso","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/10245332.2015.1106814","article-title":"Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia","volume":"21","author":"Mansour","year":"2016","journal-title":"Hematology"},{"key":"10.1016\/j.lfs.2026.124474_bb0060","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.18632\/oncotarget.1504","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia","volume":"5","author":"Folgiero","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2026.124474_bb0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/bloodadvances.2021004878","article-title":"An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia","volume":"6","author":"Ragaini","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.lfs.2026.124474_bb0070","doi-asserted-by":"crossref","unstructured":"Tettamanti, S., Pievani, A., Biondi, A., Dotti, G., Serafini, M., 2021. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia 2021 36:1 36, 13\u201322. doi:https:\/\/doi.org\/10.1038\/s41375-021-01350-x.","DOI":"10.1038\/s41375-021-01350-x"},{"key":"10.1016\/j.lfs.2026.124474_bb0075","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.3389\/ebm.2025.10235","article-title":"Bone marrow immune cells and drug resistance in acute myeloid leukemia","volume":"250","author":"Zhang","year":"2025","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2026.124474_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651687","article-title":"Investigating the role of Indoleamine 2,3-dioxygenase in acute myeloid leukemia: a systematic review","volume":"12","author":"Wells","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0085","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5045\/br.2018.53.4.294","article-title":"Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype","volume":"53","author":"Arandi","year":"2018","journal-title":"Blood Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0090","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.18632\/oncotarget.1504","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia","volume":"5","author":"Folgiero","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2026.124474_bb0095","doi-asserted-by":"crossref","unstructured":"Grishanova, A.Y., Perepechaeva, M.L., 2024. Kynurenic acid\/AhR signaling at the junction of inflammation and cardiovascular diseases. Int. J. Mol. Sci. 2024, Vol. 25, page 6933 25, 6933. doi:https:\/\/doi.org\/10.3390\/IJMS25136933.","DOI":"10.3390\/ijms25136933"},{"key":"10.1016\/j.lfs.2026.124474_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4615-0135-0_21","article-title":"T cell apoptosis by kynurenines","volume":"527","author":"Fallarino","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2026.124474_bb0105","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2026.124474_bb0110","doi-asserted-by":"crossref","unstructured":"Mbongue, J.C., Nicholas, D.A., Torrez, T.W., Kim, N.S., Firek, A.F., Langridge, W.H.R., 2015. The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines (Basel). 3, 703. doi:https:\/\/doi.org\/10.3390\/VACCINES3030703.","DOI":"10.3390\/vaccines3030703"},{"key":"10.1016\/j.lfs.2026.124474_bb0115","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/onci.21716","article-title":"IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan","volume":"1","author":"Metz","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lfs.2026.124474_bb0120","doi-asserted-by":"crossref","unstructured":"Chi, H., 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 2012 12:5 12, 325\u2013338. doi:https:\/\/doi.org\/10.1038\/nri3198.","DOI":"10.1038\/nri3198"},{"key":"10.1016\/j.lfs.2026.124474_bb0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOT.0b013e3282f3dee1","article-title":"The role of tryptophan catabolism in acquisition and effector function of memory T cells","volume":"13","author":"Dai","year":"2008","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.lfs.2026.124474_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2026.124474_bb0135","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nbt.4180","article-title":"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.lfs.2026.124474_bb0145","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.it.2018.10.010","article-title":"The aryl hydrocarbon receptor: connecting immunity to the microenvironment","volume":"39","author":"Shinde","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0150","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0155","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124474_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?","volume":"2011","author":"Son","year":"2011","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.lfs.2026.124474_bb0165","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR","volume":"5","author":"Litzenburger","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2026.124474_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00551","article-title":"Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research","volume":"5","author":"Nguyen","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0175","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1074\/jbc.M113.505578","article-title":"Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-\u03baB","volume":"289","author":"Vogel","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124474_bb0180","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2244330","article-title":"L-kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes","volume":"12","author":"Schlichtner","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.lfs.2026.124474_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2025.100658","article-title":"Kynurenine promotes the immune escape of colorectal cancer cells via NAT10-mediated ac4C acetylation of PD-L1","volume":"80","author":"Wang","year":"2025","journal-title":"Clinics"},{"key":"10.1016\/j.lfs.2026.124474_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: the Janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0195","doi-asserted-by":"crossref","unstructured":"Lugo-Huitr\u00f3n, R., Blanco-Ayala, T., Ugalde-Mu\u00f1iz, P., Carrillo-Mora, P., Pedraza-Chaverr\u00ed, J., Silva-Adaya, D., Maldonado, P.D., Torres, I., Pinz\u00f3n, E., Ortiz-Islas, E., L\u00f3pez, T., Garc\u00eda, E., Pineda, B., Torres-Ramos, M., Santamar\u00eda, A., La Cruz, V.P. De, 2011. On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. Neurotoxicol. Teratol. 33, 538\u2013547. doi:https:\/\/doi.org\/10.1016\/J.NTT.2011.07.002.","DOI":"10.1016\/j.ntt.2011.07.002"},{"key":"10.1016\/j.lfs.2026.124474_bb0200","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Gonz\u00e1lez, A., Alvarez-Idaboy, J.R., Galano, A., 2015. Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes. J. Mol. Model. 2015 21:8 21, 1\u201311. doi:https:\/\/doi.org\/10.1007\/S00894-015-2758-2.","DOI":"10.1007\/s00894-015-2758-2"},{"key":"10.1016\/j.lfs.2026.124474_bb0205","article-title":"3-hydroxykynurenine is a ROS-inducing cytotoxic tryptophan metabolite that disrupts the TCA cycle","author":"Buchanan","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.lfs.2026.124474_bb0210","doi-asserted-by":"crossref","first-page":"e70268","DOI":"10.1002\/mco2.70268","article-title":"Oxidative stress: signaling pathways, biological functions, and disease","volume":"6","author":"Liu","year":"2025","journal-title":"MedComm (Beijing)"},{"issue":"1 17","key":"10.1016\/j.lfs.2026.124474_bb0215","first-page":"1","article-title":"Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-\u03baB signaling pathway and pyroptosis after secondary spinal cord injury","volume":"17","author":"Liu","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2026.124474_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.lfs.2026.124474_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","article-title":"Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation","volume":"94","author":"Garrison","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.lfs.2026.124474_bb0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","article-title":"Actions of Xanthurenic acid, a putative endogenous group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus","volume":"66","author":"Copeland","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2026.124474_bb0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","article-title":"Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors","volume":"112","author":"Fazio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2026.124474_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuint.2013.10.001","article-title":"Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex","volume":"73","author":"Neale","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.lfs.2026.124474_bb0245","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.lfs.2026.124474_bb0250","doi-asserted-by":"crossref","unstructured":"Mascolo, E., Vern\u00ec, F., 2020. Vitamin B6 and diabetes: relationship and molecular mechanisms. Int. J. Mol. Sci. 2020, Vol. 21, page 3669 21, 3669. doi:https:\/\/doi.org\/10.3390\/IJMS21103669.","DOI":"10.3390\/ijms21103669"},{"key":"10.1016\/j.lfs.2026.124474_bb0255","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.jbchem.a129904","article-title":"Studies on the Xanthurenic acid-insulin complex: III. Distribution of Xanthurenic acid and formation of Xanthurenic acid-insulin complex in serum","volume":"72","author":"Murakami","year":"1972","journal-title":"The Journal of Biochemistry"},{"key":"10.1016\/j.lfs.2026.124474_bb0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12035-015-9232-0","article-title":"Increased plasma levels of Xanthurenic and Kynurenic acids in type 2 diabetes","volume":"52","author":"Oxenkrug","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2026.124474_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2026.124474_bb0270","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/cncr.29302","article-title":"Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: relevance to cancer-related fatigue","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2026.124474_bb0275","doi-asserted-by":"crossref","unstructured":"Mithaiwala, M.N., Santana-Coelho, D., Porter, G.A., O'connor, J.C., 2021. Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells 2021, Vol. 10, page 1548 10, 1548. doi:https:\/\/doi.org\/10.3390\/CELLS10061548.","DOI":"10.3390\/cells10061548"},{"key":"10.1016\/j.lfs.2026.124474_bb0280","article-title":"Serotonin activates murine alveolar macrophages through 5-HT2C receptors","author":"Mikulski","year":"2010","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.lfs.2026.124474_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075426","article-title":"Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo","volume":"8","author":"Nau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124474_bb0290","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4049\/jimmunol.137.1.276","article-title":"Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists","volume":"137","author":"Sternberg","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106922","article-title":"CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism","volume":"88","author":"Wu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124474_bb0300","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2026.124474_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011825","article-title":"Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans","volume":"5","author":"Kiank","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124474_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017028","article-title":"Multiple cellular responses to serotonin contribute to epithelial homeostasis","volume":"6","author":"Pai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2026.124474_bb0315","doi-asserted-by":"crossref","first-page":"30901","DOI":"10.1074\/jbc.M802476200","article-title":"Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways","volume":"283","author":"Pai","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2026.124474_bb0320","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.7150\/ijbs.97275","article-title":"Chronic stress-induced serotonin impairs intestinal epithelial cell mitochondrial biogenesis via the AMPK-PGC-1\u03b1 Axis","volume":"20","author":"Yang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2026.124474_bb0325","doi-asserted-by":"crossref","unstructured":"Friberg, M., Behndig, A.F., Bosson, J.A., Muala, A., Barath, S., Dove, R., Glencross, D., Kelly, F.J., Blomberg, A., Mudway, I.S., Sandstr\u00f6m, T., Pourazar, J., 2023. Human exposure to diesel exhaust induces CYP1A1 expression and AhR activation without a coordinated antioxidant response. Part. Fibre Toxicol. 2023 20:1 20, 1\u201313. doi:https:\/\/doi.org\/10.1186\/S12989-023-00559-1.","DOI":"10.1186\/s12989-023-00559-1"},{"key":"10.1016\/j.lfs.2026.124474_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2012.00213","article-title":"AhR activation underlies the CYP1A autoinduction by a-998679 in rats","volume":"3","author":"Liguori","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.lfs.2026.124474_bb0335","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-079X.2008.00630.x","article-title":"Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes","volume":"45","author":"Semak","year":"2008","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0340","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1034\/j.1600-079X.2001.310408.x","article-title":"Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices","volume":"31","author":"Skene","year":"2001","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0345","doi-asserted-by":"crossref","unstructured":"Rotondo, J.C., Martini, F., Stone, T.W., Williams, R.O., 2023. Interactions of IDO and the kynurenine pathway with cell transduction systems and metabolism at the inflammation\u2013cancer interface. Cancers 2023, Vol. 15, page 2895 15, 2895. doi:https:\/\/doi.org\/10.3390\/CANCERS15112895.","DOI":"10.3390\/cancers15112895"},{"key":"10.1016\/j.lfs.2026.124474_bb0350","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2346971","article-title":"Increased Th17 and Treg levels in peripheral blood positively correlate with minimal residual disease in acute myeloid leukaemia","volume":"29","author":"Wang","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.lfs.2026.124474_bb0355","first-page":"597","article-title":"AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance: AHR pathway mediates mitochondrial oxidative phosphorylation","volume":"56","author":"Jia","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.lfs.2026.124474_bb0360","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2018-03-838474","article-title":"Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function","volume":"132","author":"Scoville","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2026.124474_bb0365","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/10428194.2015.1041388","article-title":"High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia","volume":"57","author":"Mabuchi","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.lfs.2026.124474_bb0370","first-page":"530","article-title":"Effects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line","volume":"20","author":"Mohammadi","year":"2017","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.lfs.2026.124474_bb0375","doi-asserted-by":"crossref","unstructured":"Yao, Y., Liu, Y.Y., Li, J.F., Chen, Y.S., Shi, L., Shen, Y., Yang, L.L., Yang, Q., 2025. Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia. Mol. Biomed. 2025 6:1 6, 1\u201318. doi:https:\/\/doi.org\/10.1186\/S43556-025-00262-X.","DOI":"10.1186\/s43556-025-00262-x"},{"key":"10.1016\/j.lfs.2026.124474_bb0380","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124474_bb0385","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.lfs.2026.124474_bb0390","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","article-title":"Discovery of IDO1 inhibitors: from bench to bedside","volume":"77","author":"Prendergast","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0395","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1078-0432.CCR-18-2882","article-title":"Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis","volume":"25","author":"Labadie","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0400","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lfs.2026.124474_bb0405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/1078-0432.CCR-25-2013","article-title":"IK-175, an Oral aryl hydrocarbon receptor inhibitor, alone and with Nivolumab in patients with advanced solid tumors and urothelial carcinoma","volume":"32","author":"Aggen","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0410","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007495","article-title":"Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy","volume":"11","author":"Kober","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2026.124474_bb0415","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1182\/blood-2018-99-117433","article-title":"Indoximod combined with standard induction chemotherapy is well tolerated and induces a high rate of complete remission with MRD-negativity in patients with newly diagnosed AML: results from a phase 1 Trial","volume":"132","author":"Emadi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2026.124474_bb0420","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/abbs\/gmab017","article-title":"AHR signaling pathway reshapes the metabolism of AML\/MDS cells and potentially leads to cytarabine resistance","volume":"53","author":"Jia","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.lfs.2026.124474_bb0425","first-page":"597","article-title":"AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance","volume":"56","author":"Jia","year":"2024","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.lfs.2026.124474_bb0430","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/2643-3230.BCD-21-0012","article-title":"Monocytic differentiation and AHR signaling as primary nodes of BET inhibitor response in acute myeloid leukemia","volume":"2","author":"Romine","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.lfs.2026.124474_bb0435","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1158\/0008-5472.CAN-19-0274","article-title":"Diminished AHR signaling drives human acute myeloid leukemia stem cell maintenance","volume":"79","author":"Ly","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124474_bb0440","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/10428194.2018.1543880","article-title":"Retinoic acid and 6-formylindolo(3,2-b)carbazole (FICZ) combination therapy reveals putative targets for enhancing response in non-APL AML","volume":"60","author":"Bunaciu","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.lfs.2026.124474_bb0445","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.4049\/jimmunol.2100023","article-title":"Acute myeloid leukemia alters group 1 innate lymphoid cell differentiation from a common precursor","volume":"207","author":"Lordo","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2026.124474_bb5000","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fonc.2018.00370","article-title":"Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer","volume":"8","author":"Fox","year":"2018","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124474_bb5005","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"Supplement 5","key":"10.1016\/j.lfs.2026.124474_bb5010","doi-asserted-by":"crossref","first-page":"v760","DOI":"10.1093\/annonc\/mdz268.001","article-title":"1874O - Interferon \u0263 (IFN-\u0263) gene signature and tryptophan 2,3-dioxygenase 2 (TDO2) gene expression: a potential predictive composite biomarker for linrodostat mesylate (BMS-986205; indoleamine 2,3-dioxygenase 1 inhibitor [IDO1i]) + nivolumab (NIVO)","volume":"30","author":"Luke","year":"2019","journal-title":"Ann. Oncol.","ISSN":"https:\/\/id.crossref.org\/issn\/0923-7534","issn-type":"print"},{"key":"10.1016\/j.lfs.2026.124474_bb5015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526002833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:43:01Z","timestamp":1783053781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526002833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":93,"alternative-id":["S0024320526002833"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124474","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway impact on immune evasion and inflammation in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"124474"}}